Challenges in the treatment and prevention of monkeypox infection; A comprehensive review

Jennifer Nyame1, Saranya Punniyakotti2, Kanav Khera3

  • 1Lovely Institute of Technology, Lovely School of Pharmaceutical Sciences, Lovely Professional University, Punjab 144411, India.

Acta Tropica
|June 5, 2023
PubMed

Insights

Human monkeypox (HMPX) is a zoonotic disease transmitted from animals to humans. Vaccination and public awareness are key to preventing its re-emergence.

Area of Science:

  • Zoonotic diseases
  • Infectious disease epidemiology
  • Public health

Background:

  • Human monkeypox (HMPX) is a zoonotic viral disease with a history of sporadic cases globally.
  • Transmission is linked to animal imports and international travel, posing a public health concern.
  • Previous smallpox vaccination may offer protection, but public awareness of precautions is low.

Purpose of the Study:

  • To review the epidemiology, etiology, transmission, clinical features, and treatment of human monkeypox.
  • To highlight HMPX as a re-emergent infectious disease requiring monitoring and prevention strategies.

Main Methods:

  • This review synthesizes existing data on human monkeypox.
  • Information was collated from reported cases, epidemiological studies, and clinical observations.

Main Results:

  • Human monkeypox (HMPX) cases are primarily linked to animal trade and travel.
  • Smallpox vaccination demonstrates protective benefits against monkeypox.
  • JYNNEOS is an approved vaccine for improving clinical outcomes.
  • Public knowledge gaps regarding HMPX prevention persist, especially post-COVID-19.

Conclusions:

  • Human monkeypox (HMPX) is a significant public health threat requiring ongoing surveillance and research.
  • Vaccination and enhanced public health education are crucial for controlling HMPX outbreaks.
  • Addressing public ignorance about safety measures is vital to prevent re-emergence.